02.12.25 -- Training Specifically For Tech Transfer Skills Does Exist

Discover the critical success factors needed for rapid prototype selection and efficient progression to clinical evaluation in nasal dosage form development. This webinar highlights the significance of target product selection and its influence on formulation and clinical outcomes. Learn More.

As consumer preferences for natural and organic products rise, pharma and nutraceutical companies are increasingly shifting to plant-based APIs. This article shares new market research, including a spotlight on cannabis-based APIs.

The support of an experienced CDMO is critical to overcoming complexity when working with highly potent APIs and when solving solubility challenges.

Unlock the potential of nasal inhalation for delivering active pharmaceutical ingredients by exploring the benefits of both liquid and dry powder formulations as companies drive innovation in the field.

Explore the pros and cons of marketed amorphous solid dispersions with so-far unpublished data as well as a green alternative to ASDs: best-in-class nanotechnology to manufacture nanocrystals.

In the era of seamless development, reducing time to the clinic and getting rapid approval is key. An integrated approach can accelerate timelines, avoid communication pitfalls, and improve outcomes.

Review the key trends and challenges shaping the CDMO industry as well as the tools helping a leading CDMO meet the growing demand for pediatric formulations and taste-masking solutions.

Learn how a top 20 U.S.-based pharma company achieved more capacity to meet commercial supply needs in an accelerated timeline followed by pre-approval inspection with the help of a CMO partner.

Enzalutamide and apalutamide, used for advanced prostate cancer, are not druggable in their crystalline form due to low solubility, so they are marketed as amorphous solid dispersions. Join on March 12th to learn how Nanoforming these drugs into high-load nanocrystals can reduce pill size, enhance performance, and extend market exclusivity while benefiting patients.

While there are many benefits to oral MR formulations, there are also several challenges in developing them, including ensuring that the formulation can withstand changes in environmental conditions.

We have defined work flows to assess and select solid forms in a cost and time efficient manner that meets the needs of each individual program.

Liquid-filled two-piece capsules offer advantages like scalability, faster absorption, simpler packaging, and greater product stability.